PermaWay 600 mg intramammary suspension for cattle
PermaWay 600 mg intramammary suspension for cattle
Authorised
- Cloxacillin hemibenzathine
Product identification
Medicine name:
PermaWay 600 mg intramammary suspension for cattle
Permaway 600 mg Suspensie voor intramammair gebruik
Permaway 600 mg Suspension intramammaire
Permaway 600 mg Suspension zur intramammären Anwendung
Active substance:
- Cloxacillin hemibenzathine
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin hemibenzathine765.40/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Meat and offal28day
-
Milkno withdrawal periodMilk: Interval between treatment and calving is 42 days or longer: 4 days after calving.Interval between treatment and calving is less than 42 days: 46 days after treatment
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- box containing 96 intramammary syringes
- box containing 48 intramammary syringes
- box containing 24 intramammary syringes
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V589635
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0384/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.